Multicenter Retrospective Database on Prognostic and Predictive Factors in Patients With Neuroendocrine Tumors

Multicenter retrospective longitudinal analytical study of patients with neuroendocrine tumors.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Conditions

Neuroendocrine Tumors Carcinoma;Endocrine Neoplasms Neoplasms by Histologic Type Neoplasms, Germ Cell and Embryonal Neoplasms, Nerve Tissue Neuroectodermal Tumors

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Universidade Federal do Ceará/HOSPITAL UNIVERSITARIO WALTER CANTIDIO, Fortaleza, Ceará, Brazil

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients aged 18 years or older and with histologically confirmed neuroendocrine tumors;
Metastatic or inoperable disease;
Patients with clinical information about the therapies received, including exclusive palliative care.

Exclusion criteria

Lack of data on survival outcomes and/or details on treatments received.

Treatment and study plan

Primary outcomes

Overall survival

Time frame: 2022

Secondary outcomes

Response rate per RECIST 1.1;

Time frame: 2022
Progression-free survival by RECIST 1.1 from D1 of each treatment;

Time frame: 2022
Symptom control time

Time frame: 2022

Improvement of symptoms and/or stabilization of radiological disease in non-functioning ENT, at the physician's discretion
Incidence of complications of the disease and/or treatments, defined by adverse events

Time frame: 2022

Sponsors and collaborators

Lead sponsor

Latin American Cooperative Oncology Group

Other

Registry information

Important dates

Study start: 2020
Primary completion: 2025
Study completion: 2025
First posted: Dec 23, 2021
Registry last updated: Feb 12, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Active, Not Recruiting